Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re. possible offer

11 Feb 2020 07:00

RNS Number : 5659C
GKSD Investment Holding SA
11 February 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "TAKEOVER CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE TAKEOVER CODE AND THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE

 

FOR IMMEDIATE RELEASE

 

11 February 2020

 

Statement re. possible offer

 

GKSD Investment Holding SA ("GKSD"), a company backed by sponsors of Gruppo San Donato ("GSD"), notes the announcement by NMC Health plc ("NMC" or the "Company") that NMC has received an approach from GK Investment Holding Group SA ("GKI") regarding a possible offer for NMC.

 

GKSD confirms that GKI is acting as adviser to GKSD and made the approach on its behalf and that GKSD is in the preliminary stages of considering an offer for NMC.

 

Takeover Code notices

 

This announcement does not amount to a firm intention to make an offer and accordingly there can be no certainty that an offer will made, nor as to the terms on which any offer will be made.

 

GKSD confirms that in accordance with Rule 2.6(a) of the Code, GKSD is required, by no later than 5.00 p.m. on 9 March 2020, to either announce a firm intention to make an offer for NMC in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Takeover Code applies. This deadline may be extended with the consent of the Panel on Takeovers and Mergers in accordance with Rule 2.6(c) of the Takeover Code.

 

For the purposes of the Takeover Code, any offer if made is likely to be in cash. GKSD reserves the right to vary the form and mix of any consideration.

 

Enquiries

 

Rothschild & Co

+44 207 280 5000

Hedley Goldberg

Thibault Poirier

 

 

Goldman Sachs International

+44 20 7774 1000

Ben Thorpe

Chris Emmerson

 

 

Important notice related to financial adviser

 

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting as financial adviser for GKSD and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than GKSD for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

 

Goldman Sachs International, which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the PRA and the Financial Conduct Authority ("FCA") in the United Kingdom, is acting exclusively for GKSD and for no one else in connection with the possible offer and will not be responsible to anyone other than GKSD for providing the protections afforded to its clients or for providing advice in relation to the possible offer, the contents of this announcement or any other matters referred to in this announcement.

 

Disclosure requirements of the Takeover Code

 

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position disclosure or a dealing disclosure.

 

Rule 26.1 disclosure

 

In accordance with Rule 26.1 of the Takeover Code, a copy of this announcement will be available (subject to certain restrictions relating to persons resident in restricted jurisdictions) at www.grupposandonato.it by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Additional Information

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise. Any offer, if made, will be made solely by certain offer documentation which will contain the full terms and conditions of any offer, including details of how it may be accepted. The distribution of this announcement in jurisdictions other than the United Kingdom and the availability of any offer to shareholders of NMC who are not resident in the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom or shareholders of NMC who are not resident in the United Kingdom will need to inform themselves about, and observe any applicable requirements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OFDEAAAFFFKEEEA
Date   Source Headline
6th Mar 202010:52 amBUSForm 8.3 - NMC Health plc
6th Mar 20209:47 amRNSAMENDMENTForm 8.3 - NMC Health plc
6th Mar 20209:40 amRNSAMENDMENT Form 8.3 - NMC Health plc
6th Mar 20209:34 amRNSForm 8.3 - NMC Health plc
6th Mar 20209:23 amRNSForm 8.3 - NMC Health plc
6th Mar 20207:00 amRNSForm 8.3 - NMC Health PLC
5th Mar 20205:34 pmRNSForm 8.3 - "NMC Health Plc"
5th Mar 20203:24 pmBUSForm 8.5 (EPT/NON-RI) - NMC HEALTH PLC
5th Mar 20203:20 pmRNSForm 8.3 - NMC Health plc
5th Mar 20203:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - NMC Health plc
5th Mar 20202:51 pmRNSForm 8.3 - NMC Health plc
5th Mar 202011:44 amRNSForm 8.5 (EPT/RI)- NMC Health plc
5th Mar 202011:30 amRNSHoldings in Company
5th Mar 202011:24 amRNSForm 8.5 (EPT/RI)- NMC Health plc
5th Mar 20209:28 amRNSHoldings in Company
5th Mar 20209:27 amRNSHoldings in Company
5th Mar 20209:26 amRNSHoldings in Company
5th Mar 20209:26 amRNSHoldings in Company
5th Mar 20208:38 amRNSForm 8.3 - NMC Health plc
5th Mar 20207:00 amRNSForm 8.3 - NMC Health PLC
5th Mar 20207:00 amRNSForm 8.3 - NMC Health PLC
5th Mar 20207:00 amRNSForm 8.3 - NMC Health plc
5th Mar 20207:00 amRNSForm 8.3 - NMC Health plc
5th Mar 20207:00 amRNSForm 8.3 - NMC Health PLC
4th Mar 20206:20 pmRNSNMC Health
4th Mar 20204:46 pmRNSForm 8.3 - NMC Health plc
4th Mar 20203:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - NMC Health plc
4th Mar 20201:30 pmRNSForm 8.3 - NMC Health PLC
4th Mar 202011:44 amRNSForm 8.5 (EPT/RI)- NMC Health plc
4th Mar 202011:22 amRNSForm 8.5 (EPT/RI)
4th Mar 20209:50 amRNSForm 8.5 (EPT/RI)- NMC Health plc
4th Mar 20208:37 amRNSHoldings in Company
3rd Mar 20204:45 pmRNSHoldings in Company
3rd Mar 20204:45 pmRNSHoldings in Company
3rd Mar 20204:15 pmRNSHoldings in Company
3rd Mar 20203:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - NMC Health plc
3rd Mar 20203:15 pmRNSForm 8.5 (EPT/RI)-Replacement of NMC Health plc
3rd Mar 20203:15 pmBUSForm 8.3 - NMC Health PLC Dealing Disclosure
3rd Mar 20203:10 pmRNSForm 8.5 (EPT/RI)-Replacement of NMC Health plc
3rd Mar 20203:01 pmBUSForm 8.3 - NMC Health PLC
3rd Mar 20202:18 pmRNSForm 8.3 - NMC Health PLC
3rd Mar 20202:00 pmBUSForm 8.3 - NMC Health Plc
3rd Mar 202011:56 amRNSForm 8.3 - NMC Health plc
3rd Mar 202011:40 amRNSForm 8.5 (EPT/RI)
3rd Mar 202011:00 amRNSHoldings in Company
3rd Mar 202011:00 amRNSHoldings in Company
2nd Mar 20206:30 pmRNSMajor shareholdings and PDMR interests
2nd Mar 20205:15 pmRNSForm 8.3 - NMC Health plc
2nd Mar 20204:05 pmBUSForm 8.3 - NMC Health PLC Dealing Disclosure - AMENDMENT CHANGE TO SECTION 3(A)
2nd Mar 20203:20 pmRNSForm 8.3 - NMC Health plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.